Management of adrenal insufficiency

Shazia Hussain; Sufyan Hussain; Nazim Ghouri; Karim Meeran

doi:10.4103/jdep.jdep_42_21

Journal of Diabetes and Endocrine Practice, Table of Contents

CC BY-NC-ND 4.0 · Journal of Diabetes and Endocrine Practice 2021; 04(03): 90-92
DOI: 10.4103/jdep.jdep_42_21

Commentary

Management of adrenal insufficiency

Shazia Hussain

Department of General Medicine, Endocrinology and Metabolic Medicine, Homerton University Hospital, London

,

Sufyan Hussain

¹Department of Diabetes and Endocrinology, St Thomas' Hospital

²Department of Diabetes and Endocrinology, King's College, London

,

Nazim Ghouri

³Queen Elizabeth University Hospital

⁴Institute of Cardiovascular and Medical Sciences, University of Glasgow

⁵Department of Diabetes and Endocrinology, Queen Elizabeth University Hospital, Glasgow

,

Karim Meeran

⁶Department of Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London

⁷Department of Diabetes and Endocrinology, Imperial College London NHS Trust, London

› Author Affiliations

Abstract

Full Text

References

References
1 Simpson H, Tomlinson J, Wass J, Dean J, Arlt W. Guidance for the prevention and emergency management of adult patients with adrenal insufficiency. Clin Med (Lond) 2020;20:371-8.
2 Bouziane T, Belmahi N, Salhi H, El Ouahabi H. Knowledge and attitude of patients with adrenal insufficiency. Ann Afr Med 2020;19:252-7.
3 Keil MF, Van Ryzin C. The key to adrenal insufficiency education: Repetition, repetition, repetition. Pediatr Endocrinol Rev 2017;14:448-53.
4 Kampmeyer D, Haas CS, Moenig H, Harbeck B. Self-management in adrenal insufficiency – Towards a better understanding. Endocr J 2017;64:379-85.
5 White K, Arlt W. Adrenal crisis in treated Addison's disease: A predictable but under-managed event. Eur J Endocrinol 2010;162:115-20.
6 Kampmeyer D, Lehnert H, Moenig H, Haas CS, Harbeck B. A strong need for improving the education of physicians on glucocorticoid replacement treatment in adrenal insufficiency: An interdisciplinary and multicentre evaluation. Eur J Intern Med 2016;33:e13-5.
7 Shepherd LM, Tahrani AA, Inman C, Arlt W, Carrick-Sen DM. Exploration of knowledge and understanding in patients with primary adrenal insufficiency: A mixed methods study. BMC Endocr Disord 2017;17:47.
8 Harbeck B, Brede S, Witt C, Süfke S, Lehnert H, Haas C. Glucocorticoid replacement therapy in adrenal insufficiency – A challenge to physicians? Endocr J 2015;62:463-8.
9 Newman C, Kgosidalwa O, Hakami OA, Kennedy C, Grogan L, Agha A. Multiple endocrinopathies, hypercalcaemia and pancreatitis following combined immune checkpoint inhibitor use – Case report and review of literature. BMC Endocr Disord 2021;21:33.
10 Higham CE, Olsson-Brown A, Carroll P, Cooksley T, Larkin J, Lorigan P, et al. Society for endocrinology endocrine emergency guidance: Acute management of the endocrine complications of checkpoint inhibitor therapy. Endocr Connect 2018;7:G1-7.
11 Beshyah SA, Ali KF. Management of adrenal insufficiency: A survey of perceptions and practices of physicians from the Middle East and North Africa. J Diabetes Endocr Pract 2021;4:125-30.
12 Liew SY, Akker SA, Guasti L, Pittaway JF. Glucocorticoid replacement therapies: Past, present and future. Curr Opin Endocr Metab Res 2019;8:152-9.
13 Isidori AM, Venneri MA, Graziadio C, Simeoli C, Fiore D, Hasenmajer V, et al. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): A single-blind, randomised control trial. Lancet Diabetes Endocrinol 2018;6:173-85.
14 Iqbal K, Halsby K, Murray RD, Carroll PV, Petermann R. Glucocorticoid management of adrenal insufficiency in the United Kingdom: Assessment using real-world data. Endocr Connect 2019;8:20-31.
15 Choudhury S, Meeran K. Glucocorticoid replacement in Addison disease. Nat Rev Endocrinol 2018;14:562.
16 Williams EL, Choudhury S, Tan T, Meeran K. Prednisolone replacement therapy mimics the circadian rhythm more closely than other glucocorticoids. J Appl Lab Med 2016;1:152-61.
17 Khanna A, Khurana R, Kyriacou A, Davies R, Ray DW. Management of adrenocortical insufficiency with continuous subcutaneous hydrocortisone infusion: Long-term experience in three patients. Endocrinol Diabetes Metab Case Rep 2015;2015:150005.
18 Oksnes M, Björnsdottir S, Isaksson M, Methlie P, Carlsen S, Nilsen RM, et al. Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of Addison's disease: A randomized clinical trial. J Clin Endocrinol Metab 2014;99:1665-74.
19 Dineen R, Stewart PM, Sherlock M. Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy. Clin Endocrinol (Oxf) 2019;90:3-14.
20 Arlt W, Baldeweg SE, Pearce SH, Simpson HL. Endocrinology in the time of COVID-19: Management of adrenal insufficiency. Eur J Endocrinol 2020;183:G25-32.
21 Prete A, Taylor AE, Bancos I, Smith DJ, Foster MA, Kohler S, et al. Prevention of adrenal crisis: Cortisol responses to major stress compared to stress dose hydrocortisone delivery. J Clin Endocrinol Metab 2020;105:dgaa133.
22 Pofi R, Tomlinson JW. Glucocorticoids in pregnancy. Obstet Med 2020;13:62-9.
23 Hussain S, Hussain S, Mohammed R, Meeran K, Ghouri N. Fasting with adrenal insufficiency: Practical guidance for healthcare professionals managing patients on steroids during Ramadan. Clin Endocrinol (Oxf) 2020;93:87-96.